About Niranjan Sardesai
Form D filings for GENEOS Therapeutics from 2019 to 2023 list Niranjan Sardesai as chief executive officer and director.
Niranjan Sardesai first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Niranjan Sardesai in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Niranjan Sardesai works with at each company, as listed on that company's latest Form D.
GENEOS Therapeutics, Inc. · Form D, Apr 13, 2023
LH
Laurent Humeau
Director
JE
James Eadie
Director
SB
Samuel Broder
Director
SL
Sangwoo Lee
Director
CC
Casey Cunningham
Director
TF
Ted Fjallman
Director